SCHEMBL351633

SCHEMBL351633

CN(C(=O)c1ccc(Cl)nc1)c1nsc2cccc(Cl)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.40
MEN1 O00255 4/20 0.40
NAPRT Q6XQN6 1/20 0.38
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 4/20 0.36
ALDH1A1 P00352 3/20 0.36
TDP1 Q9NUW8 1/20 0.35
POLB P06746 3/20 0.35
NPC1 O15118 2/20 0.34
DGAT1 O75907 1/20 0.34
GAA P10253 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
GPBAR1 Q8TDU6 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167578 0.87 L3MBTL1 (0.42) KMT2AMEN1NAPRTRAB9ASMN1; SMN2
SCHEMBL10167655 0.86 P2RX7 (0.37) GPBAR1
SCHEMBL358113 0.85 KMT2A (0.40) KMT2AMEN1NAPRTRAB9ASMN1; SMN2
SCHEMBL10167464 0.84 LMNA (0.45) KMT2ARAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL353442 0.83 LMNA (0.36) KMT2AMEN1NAPRTRAB9ASMN1; SMN2
SCHEMBL10167555 0.83 KCNQ3 (0.36) KMT2AMEN1NAPRTRAB9ASMN1; SMN2
SCHEMBL350288 0.79 POLB (0.39) KMT2AMEN1RAB9ALMNAALDH1A1
SCHEMBL4387156 0.77 POLB (0.38) LMNAALDH1A1POLBCYP2C19HPGD
SCHEMBL352691 0.76 KMT2A (0.39) KMT2AMEN1NAPRTRAB9ASMN1; SMN2
SCHEMBL10167447 0.75 ALDH1A1 (0.40) KMT2ALMNAALDH1A1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064196-B1 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2012-03-14 EP disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 KMT2A 2749/4885MEN1 3020/4885NAPRT 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.